 |
 According
to a new study presented at the annual meeting of the American
Society for Laser Medicine and Surgery in Reno, Nevada,
recurrent (returning) breast cancer in
the chest wall may be treated with a combination of a drug and laser
light. The treatment, called photodynamic therapy (PDT), can
successfully eliminate cancerous tumors without damaging the
surrounding normal tissue, according to Thomas S. Mang, MD, the lead
researcher.
To treat the patients, the researchers gave each breast
cancer patient 0.08 milligrams per kilogram (mg/kg) body weight of a
photosensitizing (activated by light) drug called Photofrin (generic
name, porfimer sodium). A 0.08 mg/kg dosage is lower than the
standard Photofrin dose of 2.0 mg/kg. According to Dr. Mang, the
researchers lowered the drug dosage so that they could deliver laser
light deep within the tumor where the drug concentration is highest
without harming the surrounding normal breast tissue. After an
injection of Photofrin, the patients were treated with an intense
laser beam that activates Photofrin. The laser was aimed directly at
the tumor with an
endoscope, causing Photofrin to produce
a toxic chemical that kills cancer cells.
A total of 102 recurrent breast cancer tumors in the chest
wall were treated in the study, and 89% of those tumors were
eliminated. Among the other 11% of the tumors, 8% were successfully
reduced in size. Only 3% of tumors did not respond to the
photodynamic therapy. All of the tumors ranged in size from one
fifth of an inch to three and a half inches. The patients chosen for
the study had all been previously treated with surgery,
radiation or chemotherapy without success.
The researchers believe that photodynamic therapy could
possibly be used on other forms of cancer. Because the normal tissue
surrounding the tumor cells absorbs less of the drug than malignant
(cancerous) tissue, the key is to find the drug-to-light ratio for
each tumor type that will most effectively destroy the malignant
tissue while not harming the surrounding normal tissue.
According to Dr. Mang, the results of the study show that low
dose photodynamic therapy has more applications than originally
thought. Currently, photodynamic therapy is used in non-small-cell
lung cancer patients and for obstructing esophageal tumors. Dr. Mang
says photodynamic therapy could provide "very good local control" of
recurrent breast cancer.
A diagnosis of recurrent breast cancer is often more
devastating or psychologically difficult for a woman than her
initial breast cancer diagnosis. Breast cancer most commonly recurs
in the same area as the original cancer had occurred. A recurrence
of non-invasive breast cancer such as
ductal carcinoma in
situ (DCIS)
is usually less serious than a recurrence of invasive cancer. In
general, invasive local recurrences are more aggressive since they
have a second chance of spreading (
metastasizing) to other areas of the body.
Additional Resources and
References:
- The April 11, 2000 Reuters Health report, "Breast Cancer Lesions on Chest Wall Respond to
Low-Dose Photodynamic Therapy," is available at
http://womenshealth.medscape.com/reuters/prof/2000/04/04.11/20000411clin012.asp
- The April 13, 2000 Oncology.com
report by Geri Clark, "Laser Therapy Successfully Treats Breast
Cancer Lesions in Chest Wall," is available at
http://www.oncology.com/news/news_view/1,1017,2916_2917_1,00.asp
- The April 8, 2000 EurekAlert
report, "Drugs with Lasers Offer Promising New Cancer Treatment,"
is available at
http://www.cancerfacts.com/News.asp?CancerTypeId=5&CB=&NewsId=430
Return to Breast Health News
Archives |
